🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
14/09/2022 0,6900 USD
14/06/2022 0,6900 USD
14/03/2022 0,6900 USD
14/12/2021 0,6900 USD
14/09/2021 0,6500 USD
14/06/2021 0,6500 USD
12/03/2021 0,6202 USD
14/12/2020 0,6202 USD
14/09/2020 0,5821 USD
12/06/2020 0,5821 USD
13/03/2020 0,5821 USD
13/12/2019 0,5821 USD
13/09/2019 0,5248 USD
14/06/2019 0,5248 USD
14/03/2019 0,5248 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/05/1977 1,36 1,38 1,35 1,37 +0,49% 1,95% 4.180.262
25/05/1977 1,39 1,39 1,35 1,36 -2,38% 2,62% 1.554.394
24/05/1977 1,39 1,40 1,38 1,39 -0,24% 1,66% 1.712.851
23/05/1977 1,41 1,41 1,39 1,39 -0,94% 1,17% 1.184.659
20/05/1977 1,41 1,41 1,39 1,41 -0,70% 1,41% 2.350.454
19/05/1977 1,42 1,42 1,41 1,42 +0,00% 1,17% 1.384.618
18/05/1977 1,41 1,42 1,41 1,42 +0,23% 0,94% 2.422.138
17/05/1977 1,40 1,42 1,40 1,41 +0,94% 1,42% 2.444.774
16/05/1977 1,38 1,41 1,38 1,40 +1,20% 1,68% 1.233.706
13/05/1977 1,38 1,40 1,38 1,38 +0,00% 1,20% 2.158.042
12/05/1977 1,37 1,38 1,36 1,38 +1,21% 2,18% 1.350.662
11/05/1977 1,40 1,40 1,36 1,37 -2,37% 3,31% 1.607.213
10/05/1977 1,40 1,42 1,40 1,40 +0,24% 1,90% 3.531.341
09/05/1977 1,40 1,42 1,39 1,40 +0,00% 1,90% 1.305.389
06/05/1977 1,38 1,40 1,38 1,40 +0,96% 1,68% 2.063.722
05/05/1977 1,38 1,39 1,38 1,38 +0,00% 1,20% 2.712.643
04/05/1977 1,37 1,40 1,37 1,38 +0,96% 2,42% 2.233.498
03/05/1977 1,36 1,37 1,36 1,37 +1,47% 0,73% 2.788.099
02/05/1977 1,36 1,37 1,35 1,35 -0,49% 1,46% 1.207.296
29/04/1977 1,36 1,37 1,35 1,36 +0,24% 1,47% 2.263.680
28/04/1977 1,36 1,37 1,36 1,36 +0,24% 0,97% 2.403.274
27/04/1977 1,36 1,37 1,35 1,35 -0,24% 0,97% 2.905.056
26/04/1977 1,34 1,37 1,34 1,36 +1,49% 1,98% 1.844.899
25/04/1977 1,35 1,35 1,33 1,34 -1,47% 1,96% 2.806.963
22/04/1977 1,39 1,39 1,35 1,36 -2,38% 2,86% 3.621.888
21/04/1977 1,43 1,43 1,38 1,39 -3,23% 3,24% 1.909.037
20/04/1977 1,44 1,44 1,43 1,43 -0,69% 0,69% 2.678.688
19/04/1977 1,45 1,46 1,44 1,44 -0,23% 1,37% 1.018.656
18/04/1977 1,47 1,47 1,44 1,45 -1,35% 2,04% 1.022.429
15/04/1977 1,49 1,50 1,47 1,47 -1,56% 2,01% 1.418.573